China's First Digital Therapeutics Innovation Summit: A Convergence of Global Insights and Domestic Innovation

Catalyzed by the COVID-19 pandemic and strongly supported by digital healthcare policies, digital therapeutics are opening up new frontiers in medical care. A critical challenge for the industry is how to connect various stakeholders in the digital therapeutics sector, converge key areas of interest, showcase the latest practices and cutting-edge developments, and foster a thriving digital therapeutics ecosystem.

From October 26 to 27, 2021, Probe Capital and Jianhai Technology will jointly host the “Exploring a Healthy Future – The 1st China Digital Therapeutics Innovation Summit” at the Le Méridien Hangzhou Binjiang Hotel. The finals of the “1st China Post-Consultation Disease Management and Digital Therapeutics Innovation and Entrepreneurship Competition,” co-initiated by both parties, will also take place during the same period.

This is a premier gathering and innovation arena for China’s digital therapeutics industry, designed to share the latest global concepts in digital therapeutics and showcase innovative medical practices within China. Spanning two days, the conference will feature a closed-door meeting, an innovation summit, and a grand final competition, demonstrating the vision and determination of Probes Capital and Jianhai Technology to embrace digital transformation under the paradigm of “from connectivity to diagnosis and treatment.”

Wind Vane: The First National Summit and Competition in the Vertical Field of Digital Therapeutics

Under the guidance of the People's Government of Binjiang District, Hangzhou, and hosted by Probe Capital and Jianhai Technology, with Shengshi Consulting as the organizer, this event marks China’s first summit and innovation & entrepreneurship competition dedicated to the digital therapeutics sector. It brings together industry strengths and sets the direction for industry trends.

In-Depth Focus: Government, Industry, Capital, Enterprises, and Clinical Stakeholders Convene

This summit focuses on the field of digital therapeutics, bringing together stakeholders from government, industry, investment, enterprise, and clinical sectors both in China and abroad. We have specially invitedMore than 30 clinical experts and over 50 industry leaders shared their insights, gathering more than 300 professionals to engage in in-depth discussions on industry development.

VCBeat Frontline: A Panoramic Industry Event to Explore the Cutting Edge of Digital Therapeutics

What Are the Development Prospects of the Digital Therapeutics Industry? This event will focus on cutting-edge product exploration and practical implementation, as well as the path to innovation in digital therapeutics. Through analyses of industry trends, capitalization pathways, AI empowerment, and the industrial ecosystem, it will share insights and foster discussions on the trends and market opportunities within the digital therapeutics sector.

Promoting the Ecosystem: Multi-stakeholder Collaboration to Foster a Thriving Digital Therapeutics Ecosystem

The Conference Will CommenceThe Inauguration Ceremony of the “China Digital Therapeutics and Post-Discharge Health Management Innovation Development Industry Alliance” was held, marking the establishment of the “China Digital Therapeutics Industry Fund.” Core resources from government, industry, academia, healthcare, and investment sectors—including clinical experts, international pharmaceutical and medical device giants, and leading digital therapeutics companies—will converge here.